Aptadel Therapeutics is a pre-clinical stage drug development biotech company based on RNA Aptamer technology for the treatment of cancer. Its Aptamer technology is a delivery tool platform for different therapeutic agents (siRNA, miRNA, chemotherapeutic drugs, small molecules…) that can be used in several indications.
Design and R&D
Products, services and capacities
Delivery RNA therapeutics into cancer cells
Health & Healthcare Services
Activity classification (NACE)
7211 - Research and experimental development on biotechnology